Postprandial systolic blood pressure decrease

1. Acarbose decreases postprandial systolic blood pressure decrease in humans (from 35.50±12.66 to 22.25±6.90 mmHg (P=0.000)).

   “Acarbose treatment significantly attenuated the decrease of postprandial systolic blood pressures from 35.50±12.66 to 22.25±6.90 mmHg (P=0.000)”

   Human trialpostprandial hypotension concomitant with abnormal glucose metabolism50 mgn = 20

   Acarbose, the α-glucosidase inhibitor, attenuates the blood pressure and splanchnic blood flow responses to meal in elderly patients with postprandial hypotension concomitant with abnormal glucose metabolism

   Blood pressure monitoring·1 Feb 2016

More on Acarbose

1. Postprandial systolic blood pressure decrease is associated with postprandial SMA blood flow increase in humans (r=0.351, P=0.026).

   “The maximal decrease of postprandial systolic blood pressure was positively associated with the maximal increase in postprandial SMA blood flow (r=0.351, P=0.026).”

   Human trialpostprandial hypotension concomitant with abnormal glucose metabolismn = 20

   Acarbose, the α-glucosidase inhibitor, attenuates the blood pressure and splanchnic blood flow responses to meal in elderly patients with postprandial hypotension concomitant with abnormal glucose metabolism

   Blood pressure monitoring·1 Feb 2016

More on Postprandial SMA blood flow increase